Cyrus Harmon - Net Worth and Insider Trading

Cyrus Harmon Net Worth

The estimated net worth of Cyrus Harmon is at least $10 Million dollars as of 2024-11-05. Cyrus Harmon is the Director of Olema Pharmaceuticals inc and owns about 873,311 shares of Olema Pharmaceuticals inc (OLMA) stock worth over $10 Million. Details can be seen in Cyrus Harmon's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Cyrus Harmon has not made any transactions after 2024-07-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Cyrus Harmon

To

Cyrus Harmon Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Cyrus Harmon owns 1 companies in total, including Olema Pharmaceuticals inc (OLMA) .

Click here to see the complete history of Cyrus Harmon’s form 4 insider trades.

Insider Ownership Summary of Cyrus Harmon

Ticker Comapny Transaction Date Type of Owner
OLMA Olema Pharmaceuticals inc 2024-07-30 director & Chief Technology Officer

Cyrus Harmon Latest Holdings Summary

Cyrus Harmon currently owns a total of 1 stock. Cyrus Harmon owns 873,311 shares of Olema Pharmaceuticals inc (OLMA) as of July 30, 2024, with a value of $10 Million.

Latest Holdings of Cyrus Harmon

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
OLMA Olema Pharmaceuticals inc 2024-07-30 873,311 11.91 10,396,767

Holding Weightings of Cyrus Harmon


Cyrus Harmon Form 4 Trading Tracker

According to the SEC Form 4 filings, Cyrus Harmon has made a total of 25 transactions in Olema Pharmaceuticals inc (OLMA) over the past 5 years, including 0 buys and 25 sells. The most-recent trade in Olema Pharmaceuticals inc is the sale of 5,000 shares on July 30, 2024, which brought Cyrus Harmon around $77,850.

Insider Trading History of Cyrus Harmon

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Cyrus Harmon Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Cyrus Harmon Ownership Network

Ownership Network List of Cyrus Harmon

No Data

Ownership Network Relation of Cyrus Harmon

Insider Network Chart

Cyrus Harmon Owned Company Details

What does Olema Pharmaceuticals inc do?

Who are the key executives at Olema Pharmaceuticals inc?

Cyrus Harmon is the director & Chief Technology Officer of Olema Pharmaceuticals inc. Other key executives at Olema Pharmaceuticals inc include 10 percent owner Paradigm Biocapital Advisors Lp , director & President and CEO Sean Bohen , and Chief Development Officer David C. Myles .

Olema Pharmaceuticals inc (OLMA) Insider Trades Summary

Over the past 18 months, Cyrus Harmon made 19 insider transaction in Olema Pharmaceuticals inc (OLMA) with a net sale of 338,181. Other recent insider transactions involving Olema Pharmaceuticals inc (OLMA) include a net sale of 44,370 shares made by David C. Myles , a net sale of 2,300,000 shares made by Paradigm Biocapital Advisors Lp , and a net sale of 535,000 shares made by G. Walmsley Graham .

In summary, during the past 3 months, insiders sold 0 shares of Olema Pharmaceuticals inc (OLMA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,048,074 shares of Olema Pharmaceuticals inc (OLMA) were sold and 2,245,932 shares were bought by its insiders, resulting in a net sale of 1,802,142 shares.

Olema Pharmaceuticals inc (OLMA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Olema Pharmaceuticals inc Insider Transactions

No Available Data

Cyrus Harmon Mailing Address

Above is the net worth, insider trading, and ownership report for Cyrus Harmon. You might contact Cyrus Harmon via mailing address: C/o Olema Pharmaceuticals, Inc., 512 2nd Street, 4th Floor, San Francisco Ca 94107.